351 related articles for article (PubMed ID: 28669864)
1. Is Clostridium difficile infection a risk factor for subsequent bloodstream infection?
Ulrich RJ; Santhosh K; Mogle JA; Young VB; Rao K
Anaerobe; 2017 Dec; 48():27-33. PubMed ID: 28669864
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection.
Falcone M; Russo A; Iraci F; Carfagna P; Goldoni P; Vullo V; Venditti M
Antimicrob Agents Chemother; 2016 Jan; 60(1):252-7. PubMed ID: 26482315
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and risk factors for mortality in bloodstream infection by CP-Kp, ESBL-E, Candida and CDI: A single center retrospective study.
Corcione S; Angilletta R; Raviolo S; Filippini C; Fossati L; Di Perri G; Cavallo R; De Rosa FG
Eur J Intern Med; 2018 Feb; 48():44-49. PubMed ID: 29096992
[TBL] [Abstract][Full Text] [Related]
4. Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.
Polage CR; Gyorke CE; Kennedy MA; Leslie JL; Chin DL; Wang S; Nguyen HH; Huang B; Tang YW; Lee LW; Kim K; Taylor S; Romano PS; Panacek EA; Goodell PB; Solnick JV; Cohen SH
JAMA Intern Med; 2015 Nov; 175(11):1792-801. PubMed ID: 26348734
[TBL] [Abstract][Full Text] [Related]
5. Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.
Nissle K; Kopf D; Rösler A
BMC Geriatr; 2016 Nov; 16(1):185. PubMed ID: 27846818
[TBL] [Abstract][Full Text] [Related]
6. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
[TBL] [Abstract][Full Text] [Related]
7. Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity.
Forster AJ; Daneman N; van Walraven C
J Hosp Infect; 2017 Apr; 95(4):400-409. PubMed ID: 27825674
[TBL] [Abstract][Full Text] [Related]
8. High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong.
Wong SH; Ip M; Hawkey PM; Lo N; Hardy K; Manzoor S; Hui WW; Choi KW; Wong RY; Yung IM; Cheung CS; Lam KL; Kwong T; Wu WK; Ng SC; Wu JC; Sung JJ; Lee N
J Infect; 2016 Aug; 73(2):115-22. PubMed ID: 27246801
[TBL] [Abstract][Full Text] [Related]
9. Use of tigecycline for the management of Clostridium difficile colitis in oncology patients and case series of breakthrough infections.
Brinda BJ; Pasikhova Y; Quilitz RE; Thai CM; Greene JN
J Hosp Infect; 2017 Apr; 95(4):426-432. PubMed ID: 28153556
[TBL] [Abstract][Full Text] [Related]
10. Extraintestinal Clostridium difficile infections: a single-center experience.
Gupta A; Patel R; Baddour LM; Pardi DS; Khanna S
Mayo Clin Proc; 2014 Nov; 89(11):1525-36. PubMed ID: 25245597
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
[TBL] [Abstract][Full Text] [Related]
12. Does empirical Clostridium difficile infection (CDI) therapy result in false-negative CDI diagnostic test results?
Sunkesula VC; Kundrapu S; Muganda C; Sethi AK; Donskey CJ
Clin Infect Dis; 2013 Aug; 57(4):494-500. PubMed ID: 23645849
[TBL] [Abstract][Full Text] [Related]
13. Clinical, epidemiological and microbiological characteristics of relapse and re-infection in Clostridium difficile infection.
Gómez S; Chaves F; Orellana MA
Anaerobe; 2017 Dec; 48():147-151. PubMed ID: 28830842
[TBL] [Abstract][Full Text] [Related]
14. Impact of Toxigenic Clostridium difficile Colonization on the Risk of Subsequent C. difficile Infection in Intensive Care Unit Patients.
Tschudin-Sutter S; Carroll KC; Tamma PD; Sudekum ML; Frei R; Widmer AF; Ellis BC; Bartlett J; Perl TM
Infect Control Hosp Epidemiol; 2015 Nov; 36(11):1324-9. PubMed ID: 26223207
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of Clostridium difficile infection (CDI) in a community hospital.
Daniel A; Rapose A
J Infect Public Health; 2015; 8(2):155-60. PubMed ID: 25301221
[TBL] [Abstract][Full Text] [Related]
16. Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review.
Ciricillo J; Haslam D; Blum S; Kim MO; Liu C; Paulsen G; Courter J; Danziger-Isakov L
Transpl Infect Dis; 2016 Oct; 18(5):706-713. PubMed ID: 27492796
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile infection is associated with worse long term outcome in patients with ulcerative colitis.
Navaneethan U; Mukewar S; Venkatesh PG; Lopez R; Shen B
J Crohns Colitis; 2012 Apr; 6(3):330-6. PubMed ID: 22405170
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of bloodstream infections, Clostridium difficile infections, and gut microbiota in pediatric oncology patients.
Nycz BT; Dominguez SR; Friedman D; Hilden JM; Ir D; Robertson CE; Frank DN
PLoS One; 2018; 13(1):e0191232. PubMed ID: 29329346
[TBL] [Abstract][Full Text] [Related]
19. Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study.
Skoutelis A; Pefanis A; Tsiodras S; Sipsas NV; Lelekis M; Lazanas MC; Gargalianos P; Dalekos GN; Roilides E; Samonis G; Maltezos E; Hatzigeorgiou D; Lada M; Metallidis S; Stoupis A; Chrysos G; Karnesis L; Symbardi S; Loupa CV; Giamarellou H; Kioumis I; Sambatakou H; Tsianos E; Kotsopoulou M; Georgopali A; Liakou K; Perlorentzou S; Levidiotou S; Giotsa-Toutouza M; Tsorlini-Christoforidou H; Karaiskos I; Kouppari G; Trikka-Graphakos E; Ntrivala MA; Themeli-Digalaki K; Pangalis A; Kachrimanidou M; Martsoukou M; Karapsias S; Panopoulou M; Maraki S; Orfanou A; Petinaki E; Orfanidou M; Baka V; Stylianakis A; Spiliopoulou I; Smilakou S; Zerva L; Vogiatzakis E; Belesiotou E; Gogos CA
PLoS One; 2017; 12(8):e0182799. PubMed ID: 28813492
[TBL] [Abstract][Full Text] [Related]
20. New drugs and strategies for management of Clostridium difficile colitis.
Higa JT; Kelly CP
J Intensive Care Med; 2014; 29(4):190-9. PubMed ID: 23753229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
